Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Linde
LIN
|
$588M |
| 2 |
Apple
AAPL
|
$574M |
| 3 |
Illumina
ILMN
|
$398M |
| 4 |
argenx
ARGX
|
$306M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$250M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$600M |
| 2 |
AbbVie
ABBV
|
$323M |
| 3 |
Sherwin-Williams
SHW
|
$309M |
| 4 |
Atlassian
TEAM
|
$250M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$241M |
Sector Composition
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.43% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Cimpress
CMPR
$1.5B
| $116M | 0.08% |
2,655,935
+7,589
| +0.3% | +$333K |
|
|
TWNK
227
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $115M | 0.08% |
4,630,406
-267,971
| -5% | -$6.67M |
|
228
Capital One
COF
$141B
| $114M | 0.08% |
1,188,494
+3,550
| +0.3% | +$341K |
|
229
Marsh & McLennan
MMC
$100B
| $114M | 0.08% |
685,377
-1,080
| -0.2% | -$180K |
|
230
ITT
ITT
$13.3B
| $114M | 0.08% |
1,321,807
+19,595
| +2% | +$1.69M |
|
|
ISEE
231
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $114M | 0.08% |
4,687,209
+133,305
| +3% | +$3.24M |
|
232
EnerSys
ENS
$3.86B
| $114M | 0.08% |
1,310,200
-146,461
| -10% | -$12.7M |
|
233
MSCI
MSCI
$43.1B
| $111M | 0.07% |
198,762
-43,462
| -18% | -$24.3M |
|
234
Telus
TU
$25.3B
| $111M | 0.07% |
5,595,817
-55,013
| -1% | -$1.09M |
|
235
WNS Holdings
WNS
$3.24B
| $110M | 0.07% |
1,178,198
-3,148
| -0.3% | -$293K |
|
236
Applied Materials
AMAT
$127B
| $110M | 0.07% |
892,974
+36,342
| +4% | +$4.46M |
|
237
Hillenbrand
HI
$1.83B
| $107M | 0.07% |
2,243,655
+870,549
| +63% | +$41.4M |
|
238
Ardelyx
ARDX
$1.57B
| $106M | 0.07% |
22,111,601
+2,337,268
| +12% | +$11.2M |
|
239
Saia
SAIA
$8.23B
| $106M | 0.07% |
388,301
-6,574
| -2% | -$1.79M |
|
240
Snowflake
SNOW
$74.1B
| $105M | 0.07% |
678,127
-49,094
| -7% | -$7.57M |
|
|
ALTR
241
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $104M | 0.07% |
1,446,355
-145,829
| -9% | -$10.5M |
|
242
Maximus
MMS
$4.97B
| $104M | 0.07% |
1,318,190
-183,155
| -12% | -$14.4M |
|
243
Carlisle Companies
CSL
$16.9B
| $103M | 0.07% |
455,694
-18,370
| -4% | -$4.15M |
|
244
Penumbra
PEN
$11B
| $103M | 0.07% |
368,389
-54,299
| -13% | -$15.1M |
|
245
TriNet
TNET
$3.43B
| $103M | 0.07% |
1,272,474
-86,854
| -6% | -$7M |
|
246
Marriott International Class A Common Stock
MAR
$72.5B
| $102M | 0.07% |
611,975
+241,470
| +65% | +$40.1M |
|
247
Rivian
RIVN
$17.3B
| $101M | 0.07% |
6,531,674
+33,226
| +0.5% | +$514K |
|
248
Vistra
VST
$60.7B
| $100M | 0.07% |
4,174,621
-14,457
| -0.3% | -$347K |
|
249
Jazz Pharmaceuticals
JAZZ
$7.82B
| $99.9M | 0.07% |
682,973
-413,870
| -38% | -$60.6M |
|
250
Intuitive Surgical
ISRG
$166B
| $99.8M | 0.07% |
390,848
-453,218
| -54% | -$116M |
|